Abstract

Assessing liver fibrosis in all patients with type 2 diabetes and fatty liver disease: It's time to act now.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Nonalcoholic Fatty Liver Disease in Children: Where Are We?
Jie Li
Clinical Gastroenterology and Hepatology | VOL. 20
Jie LiJie Li
08 Feb 2022
Pediatric Nonalcoholic Fatty Liver Disease: Current Thinking.
Piotr Socha ... Valerio Nobili
Journal of pediatric gastroenterology and nutrition | VOL. 66
Piotr Socha, et. al.Piotr Socha ... Valerio Nobili
01 Feb 2018
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
Naga Chalasani ... Elizabeth M Brunt
Hepatology | VOL. 55
Naga Chalasani, et. al.Naga Chalasani ... Elizabeth M Brunt
29 May 2012
The Hierarchical Model of NAFLD: Prognostic Significance of Histologic Features in NASH
Rohit Loomba ... Naga Chalasani
Gastroenterology | VOL. 149
Rohit Loomba, et. al.Rohit Loomba ... Naga Chalasani
25 Jun 2015
View more papers

More From: Journal of diabetes investigation

Paper Title
Journal
Date
Author
Factors contributing to the clinical effectiveness of imeglimin monotherapy in Japanese patients with type 2 diabetes mellitus.
Katsuhiko Hagi ... Kohjiro Ueki
Journal of diabetes investigation | VOL. -
Katsuhiko Hagi, et. al.Katsuhiko Hagi ... Kohjiro Ueki
25 May 2024
Long-term effects of ipragliflozin and pioglitazone on metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: 5 year observational follow-up of a randomized, 24 week, active-controlled trial: Effect of ipragliflozin in MASLD.
Daisuke Ito ... Akira Shimada
Journal of diabetes investigation | VOL. -
Daisuke Ito, et. al.Daisuke Ito ... Akira Shimada
22 May 2024
Predictive value of Systematic Coronary Risk Evaluation 2-Diabetes risk model and arterial stiffness for cardiovascular events in the Asian population with type 2 diabetes mellitus.
Pannipa Suwannasom ...
Journal of diabetes investigation | VOL. -
Pannipa Suwannasom, et. al.Pannipa Suwannasom ...
15 May 2024
Prevalence, awareness, treatment and control of type 2 diabetes in southeast China: A population-based study.
Xiangju Hu ... Minxia Wu
Journal of diabetes investigation | VOL. -
Xiangju Hu, et. al.Xiangju Hu ... Minxia Wu
13 May 2024
View more papers